Table 2 Flow of the study
Time point | Baseline T1 | Follow up | ||
|---|---|---|---|---|
Month 6 T2 | Month 12 T3 | Month 18 T4 | ||
ENROLLMENT: | ||||
Eligibility screen | X | |||
Informed consent | X | |||
ASSESMENTS: | ||||
Socio-demographic data | X | X | X | |
Charlson Comorbidity Index | X | X | X | |
Barthel Index | X | X | X | |
Lawton Index | X | X | X | |
SPPB | X | X | X | |
MMSE | X | X | X | |
Fried’s Frailty Phenotype Criteria | X | X | X | |
Frailty Trait Scale – short version | X | X | X | |
SHARE Frailty Instrument | X | X | X | |
35-Items Rockwood Frailty index | X | X | X | |
FRAIL scale | X | X | X | |
Gérontopôle Frailty Screening Tool | X | X | X | |
Clinical Frailty Scale | X | X | X | |
OUTCOMES: | ||||
Disability | X | X | X | |
Mortality | X | X | X | |
Falls | X | X | X | |
Incident cognitive impairment | X | X | X | |